candidate substance optimization

Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...

South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting inj...

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

POSCO Holdings Inc.'s Chairman Choi Jeong-woo is not among the company’s next CEO candidates, suggesting Choi will leave the company after ser...

LG Display Co., the world’s leading organic light-emitting diode (OLED) panel maker, will unveil its next-generation automotive display produc...

South Korea's Naver Cloud, the cloud computing arm of Naver Corp., announced on Friday that the distribution volume of Whalebook has tripled compa...

Sixth-generation (6G) communication frequency bands proposed by South Korea have been adopted as global standard candidates by the industry's freq...

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

South Korea's ISU Abxis Co. announced on Friday that its Alzheimer's treatment candidate ISU203 has received a substance patent registration decisio...

South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...

South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...

South Korea’s Nota AI, an artificial intelligence (AI) optimization model company with investment from Naver D2 Startup Factory (D2SF), an inv...

South Korea's SK Telecom Co. on Wednesday announced the launch of Cloud Radar 2.0, its next-generation cloud management platform that leverages arti...

South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...

South Korea’s KT Corp. and furniture and interior company Hyundai Livart Furniture are pursuing Premium Interior Digital Transformation (DX), ...

South Korea’s Ildong Pharmaceutical Co. will spin off its research and development (R&D) unit into the subsidiary Yunovia from Nov. 1.&nbs...

Samsung Electronics Co. announced on Wednesday that it is conducting research in collaboration with the University of Michigan to enhance fitness fe...

Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...

South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...

Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...

South Korea’s top-tier contract drugmaker Genuone Sciences Inc. with an estimated value of up to 1 trillion won ($752 million) is smooth saili...

Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...

KB Financial Group Inc. has chosen Yang Jong-hee, its vice chairman, as the sole candidate for its next chief in charge of South Korea’s leadi...

South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...

A drug candidate in South Korea could allow people seeking to lose weight to eat to their heart's content.The Center for Cognition and Sociality of ...

South Korea's CJ Logistics announced on Thursday that it has entered into a business agreement with Hanwha Vision for the development and logistics ...

Hyundai Motor Co., reeling from its weak car sales in China, has put its Chongqing plant up for sale as South Korea’s top automaker continues ...

South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...

Japanese insurer Tokio Marine Holdings Inc. is seeking to sell its units in Southeast Asia for $1 billion to major South Korean companies looking fo...

South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...